Pharmacokinetics of Multiple-Dose Darunavir in Combination with Low-Dose Ritonavir in Individuals with Mild-to-Moderate Hepatic Impairment

被引：0
|
作者：
Vanitha Sekar
Sabrina Spinosa-Guzman
Els De Paepe
Tanja Stevens
Frank Tomaka
Martine De Pauw
Richard M. W. Hoetelmans
机构：
[1] Tibotec Inc.,
[2] Tibotec BVBA,undefined
来源：
Clinical Pharmacokinetics | 2010年 / 49卷
关键词：
Ritonavir; Hepatic Impairment; Indinavir; Atazanavir; Amprenavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：343 / 350
页数：7
相关论文
共 50 条
  • [1] Pharmacokinetics of Multiple-Dose Darunavir in Combination with Low-Dose Ritonavir in Individuals with Mild-to-Moderate Hepatic Impairment
    Sekar, Vanitha
    Spinosa-Guzman, Sabrina
    De Paepe, Els
    Stevens, Tanja
    Tomaka, Frank
    De Pauw, Martine
    Hoetelmans, Richard M. W.
    CLINICAL PHARMACOKINETICS, 2010, 49 (05) : 343 - 350
  • [2] Multiple-dose pharmacokinetics and safety of desloratadine in subjects with moderate hepatic impairment
    Gupta, Samir K.
    Kantesaria, Bhavna
    Wang, Zaiqi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (10): : 1283 - 1291
  • [3] Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects
    Zhu, Li
    Persson, Anna
    Mahnke, Lisa
    Eley, Timothy
    Li, Tong
    Xu, Xiaohui
    Agarwala, Sangeeta
    Dragone, Jeffrey
    Bertz, Richard
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (03): : 368 - 377
  • [4] Influence of Low-Dose Ritonavir With and Without Darunavir on the Pharmacokinetics and Pharmacodynamics of Inhaled Beclomethasone
    Boyd, Sarita D.
    Hadigan, Colleen
    Mcmanus, Maryellen
    Chairez, Cheryl
    Nieman, Lynnette K.
    Pau, Alice K.
    Alfaro, Raul M.
    Kovacs, Joseph A.
    Calderon, Monica M.
    Penzak, Scott R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (03) : 355 - 361
  • [5] Pergolide -: Multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease
    Thalamas, C
    Rajman, I
    Kulisevsky, J
    Lledó, A
    Mackie, AE
    Blin, O
    Gillespie, TA
    Seger, M
    Rascol, O
    CLINICAL NEUROPHARMACOLOGY, 2005, 28 (03) : 120 - 125
  • [6] Irbesartan combined with low-dose hydrochlorothiazide for mild-to-moderate hypertension
    Weber, M
    Saini, R
    Kassler-Taub, K
    Reggi, D
    Ferdousi, T
    Nalence, A
    JOURNAL OF HYPERTENSION, 1998, 16 : S129 - S129
  • [7] Pharmacokinetics of Darunavir After Administration of an Oral Suspension With Low-Dose Ritonavir and With or Without Food
    Kakuda, Thomas N.
    Sekar, Vanitha
    Lavreys, Ludo
    De Paepe, Els
    Stevens, Tanja
    Vanstockem, Marc
    Vangeneugden, Tony
    Hoetelmans, Richard M. W.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (05): : 346 - 352
  • [8] Irbesartan and low-dose hydrochlorothiazide combination as long-term therapy for mild-to-moderate hypertension
    Raskin, P
    Saini, R
    Kassler-Taub, K
    Mulhall, L
    Freitag, S
    JOURNAL OF HYPERTENSION, 1998, 16 : S239 - S239
  • [9] The Effect of Renal Impairment on Multiple-Dose Pharmacokinetics of the Fixed-Dose Combination of Daclatasvir/Asunaprevir/Beclabuvir
    Adamczyk, Robert
    Sims, Karen
    Hesney, Michael
    Wind-Rotolo, Megan
    Stonier, Michele
    Penn, Ruth
    Reynolds, Laurie
    LaCreta, Frank
    AbuTarif, Malaz
    GASTROENTEROLOGY, 2015, 148 (04) : S1083 - S1083
  • [10] THE EFFECT OF RENAL IMPAIRMENT ON MULTIPLE-DOSE PHARMACOKINETICS OF THE FIXED-DOSE COMBINATION OF DACLATASVIR/ASUNAPREVIR/BECLABUVIR
    Adamczyk, R.
    Sims, K.
    Hesney, M.
    Wind-Rotolo, M.
    Stonier, M.
    Penn, R.
    Reynolds, L.
    LaCreta, F.
    AbuTarif, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S628 - S628
12345